Previous 10 | Next 10 |
home / stock / bayry / bayry news
A Mexican judge reportedly has issued a favorable ruling in a legal challenge over a government policy that seeks to ban Bayer's (BAYRY) glyphosate, in a temporary reprieve from a looming ban on the herbicide.Mexico's Reforma newspaper reports the judge based his ruling on the risk the ban wo...
Stocks continued their record performance in March with virtually all sectors going up. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $467, up 22% sequentia...
Data from a late-stage trial showed that Bayer's (BAYZF) Aliqopa (copanlisib) in combination with Rituxan (rituximab) led to an increase in progression-free survival ("PFS").Data from the CHRONOS-3 trial Bayer (BAYRY) presented at the AACR 2021 meeting showed that after a median follow-up of ...
Potential for 100 gene therapy trials to be using ClearPoint. Expect significant growth in 2H 2021 as elective surgeries rebound and clinical trials restart. Recent expansion to Europe augurs well for European biologics partners. We see potential for $100M+ revenues and 30%+ n...
Bayer ([[BAYRY]] +0.2%) is preparing to launch an auction for its Bayer Environmental Science pest control unit this summer, potentially fetching more than €2B ($2.35B), Reuters reports.The company, which continues to deleverage in the wake of its $66B acquisition of Monsanto in 2016, ...
In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer. Additionally, we are covering so...
Harris Associates’ 13F portfolio value increased from $41.07B to $51.71B this quarter. They added CNH Industrial and doubled Keurig Dr Pepper while dropping CVS Health and Baidu. The top three positions are Alphabet, CNH Industrial, and Bank of America, and they add up to ~...
The pharmaceutical industry has a reputation for resilience. Many pharma players that garnered noteworthy momentum amid the COVID-19 pandemic are holding strong even as the pandemic is on a decline. That’s because these companies are now focusing on other rare and/or chronic diseases. ...
Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva. Calyxt is targeting new high-risk/high-reward market opportunities including winter oats, hemp, and soybeans with s...
Bayer reported solid results for fiscal 2020 with revenue and core EPS being more or less stable compared to fiscal 2019. A few weeks ago, Bayer also settled the glyphosate litigations. Over the next few years, Bayer will return on the path of growth and several megatrends are hug...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...